Last Friday, the Food and Drug Administration (FDA) approved the first telehealth solution for remote adjustment of cochlear implants. The cochlear implants are limited to those from the Nucleus Cochlear Implant System. The approval allows a licensed audiologist to remotely adjust the device from their office. This will benefit cochlear implant users by cutting down their travel time and number of appointments.
There is one catch. The cochlear implant user has to have been using the implants for at least 6 months. The user must also be able to give clear and meaningful feedback on things like volume and tone so the audiologist can make adjustments.